Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Sponsors and Collaborators
Ohio State University Comprehensive Cancer Center

Ohio State University Comprehensive Cancer Center


Continue Reading

Onyx Pharmaceuticals

Contact
Ohio State University Comprehensive Cancer Center

1-800-293-5066

[email protected]

John Byrd, MD

614-293-9869

[email protected]

Principal Investigators
John Byrd, MD

Ohio State University
 
ClinicalTrials.gov Identifier
NCT01212380